Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures
Prospective Randomized Trial Comparing Navigation With Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures
Sponsor: National Institutes of Health Clinical Center (CC)
Terminated
Investigator left NIH
Other terminated trials from National Institutes of Health Clinical Center (CC)
- Autism · Aug 2025
- Hepatocellular Carcinoma · Phase NA · Jan 2025
- Cerebral Palsy · Nov 2024
- Fatigue · Sep 2021
- Platelet Transfusion Refractoriness (PTR) · Phase PHASE2 · Jul 2021
See all terminations from National Institutes of Health Clinical Center (CC)
Other Cancer trials with similar outcome
A NA clinical study on Cancer and Empyema, this trial is terminated or withdrawn. The trial is conducted by National Institutes of Health Clinical Center (CC) and has accumulated 8 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Feb 2020 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Feb 2020 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jan 2018 — Jun 2018 [monthly]
Terminated NA
Status: Completed → Terminated · Phase: PHASE2 → NA
-
Feb 2017 — Jan 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institutes of Health Clinical Center (CC)
For direct contact, visit the study record on ClinicalTrials.gov .